EP Patent

EP1670450A2 — Pharmaceutical compositions and method of using levodopa and carbidopa

Assigned to Janssen Biotech Inc · Expires 2006-06-21 · 20y expired

What this patent protects

The present invention relates to stable compositions of levodopa and carbidopa, methods of treating patients with these compositions, and methods of preparing these compositions.

USPTO Abstract

The present invention relates to stable compositions of levodopa and carbidopa, methods of treating patients with these compositions, and methods of preparing these compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP1670450A2
Jurisdiction
EP
Classification
—
Expires
2006-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.